Evidence map›Paper›PMID 28674728›Full record

ReviewCellular and molecular life sciences : CMLS2017

New imaging probes to track cell fate: reporter genes in stem cell research.

Piotr Jurgielewicz, Stefan Harmsen, Elizabeth Wei, Michael H Bachmann, Richard Ting, Omer Aras

Open access · greenAbstract readReview
In one paragraph

Review in Cellular and molecular life sciences : CMLS, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Pre-clinical SPECT and SPECT-CT in Oncology.Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer · 2026
    Review
  3. Review
  4. Reporter Alleles in hiPSCs: Visual Cues on Development and Disease.International journal of molecular sciences · 2024
    Review
  5. Review
  6. Positron emission tomography probes for stem cell monitoring: a review.American journal of translational research · 2024
    Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Mesenchymal Stem Cells for Neurological Disorders.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2021
    Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 1 country.

Piotr JurgielewiczPennsylvania State University College of Medicine, Hershey, PA, 17033, USA.
Stefan HarmsenDepartment of Pediatrics, Stanford University, Stanford, CA, 94305, USA.
Elizabeth WeiBrown University, Providence, RI, 02903, USA.
Michael H BachmannDepartment of Pediatrics, Stanford University, Stanford, CA, 94305, USA.
Richard TingDepartment of Radiology, Weill Cornell Medicine, Weill Cornell Medical College, New York, NY, 10065, USA.
Omer ArasDepartment of Radiology, Memorial Sloan Kettering Cancer Center, 300 East 66th Street, Suite 1511, New York, NY, 10065, USA. araso@mskcc.org.
Stanford University · USBrown University · USMemorial Sloan Kettering Cancer Center · USPennsylvania State University · USWeill Cornell Medicine · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

Cell fate is a concept used to describe the differentiation and development of a cell in its organismal context over time. It is important in the field of regenerative medicine, where stem cell therapy holds much promise but is limited by our ability to assess its efficacy, which is mainly due to the inability to monitor what happens to the cells upon engraftment to the damaged tissue. Currently, several imaging modalities can be used to track cells in the clinical setting; however, they do not satisfy many of the criteria necessary to accurately assess several aspects of cell fate. In recent years, reporter genes have become a popular option for tracking transplanted cells, via various imaging modalities in small mammalian animal models. This review article examines the reporter gene strategies used in imaging modalities such as MRI, SPECT/PET, Optoacoustic and Bioluminescence Imaging. Strengths and limitations of the use of reporter genes in each modality are discussed.

Indexed as

AnimalsCell DifferentiationCell TrackingDiagnostic ImagingGenes, ReporterHumansRegenerative MedicineStem Cell ResearchStem CellsStem Cell TransplantationCell imaging modalitiesMolecular imagingStem cell engraftmentStem cell tracking

Identifiers

PMID28674728
PMCPMC5665705
OpenAlexW2731337855

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.